FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bernd Kronenberger

Research Profile

Disorders

Hepatitis C, Chronic

Chemicals & Drugs

Living Beings

Hepacivirus

Procedures

Drug Therapy, Combination

Concepts & Ideas

Physiology

Anatomy

Livers

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Oliver Waidmann; Stefan Zeuzem; Friederike Brunner; Eva Herrmann; Albrecht Piiper; Bernd Kronenberger
Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis.
J Peveling-Oberhag; Christoph Sarrazin; S Susser; Stefan Zeuzem; H Farnik; Eva Herrmann; Bernd Kronenberger; Wolf Peter Hofmann
Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs.
Martin Walter Welker; Christoph Welsch; Stefan Zeuzem; S Susser; C Füller; Eva Herrmann; Bernd Kronenberger; D Perner; Christoph Sarrazin
Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site-directed mutagenesis of an NS4B aminoterminal basic leucine zipper.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bernd Kronenberger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Oliver Waidmann; Stefan Zeuzem; Friederike Brunner; Eva Herrmann; Albrecht Piiper; Bernd Kronenberger
Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis.
Journal of hepatology 2013;58(5):956-61.
2013: J Peveling-Oberhag; Christoph Sarrazin; S Susser; Stefan Zeuzem; H Farnik; Eva Herrmann; Bernd Kronenberger; Wolf Peter Hofmann
Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs.
Journal of viral hepatitis 2013;20(4):234-9.
2012: Martin Walter Welker; Christoph Welsch; Stefan Zeuzem; S Susser; C Füller; Eva Herrmann; Bernd Kronenberger; D Perner; Christoph Sarrazin
Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site-directed mutagenesis of an NS4B aminoterminal basic leucine zipper.
Journal of viral hepatitis 2012;19(11):775-83.
2012: Jörg Haupenthal; Otto Kollmar; Huedayi Korkusuz; Susanne Kriener; Bernd Kronenberger; Thomas Longerich; Alexander Benz; Verena Bihrer; Marta Canamero; Knut Engels; Thomas Pleli; Swantje Richter; Christian Schmithals; Thomas J Vogl; Oliver Waidmann; Stefan Zeuzem; Albrecht Piiper
Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels.
Neoplasia (New York, N.Y.) 2012;14(5):410-9.
2012: Oliver Waidmann; Stefan Zeuzem; Verena Bihrer; Bernd Kronenberger; Albrecht Piiper; Nicole Forestier
Pretreatment serum microRNA-122 is not predictive for treatment response in chronic hepatitis C virus infection.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2012;44(5):438-41.
2012: Oliver Waidmann; Stefan Zeuzem; Friederike Brunner; Verena Köberle; Albrecht Piiper; Bernd Kronenberger
Serum microRNA-122 predicts survival in patients with liver cirrhosis.
PloS one 2012;7(9):e45652.
2012: Bernd Kronenberger; Malte Bachmann; Friederike Brunner; Natalie Filmann; Eva Herrmann; Lisa Kapper; Josef Pfeilschifter; Albrecht Piiper; Ina Rudloff; Oliver Waidmann; Stefan Zeuzem; Heiko Muhl
Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study.
BMC medicine 2012;10():102.
2012: Martin Walter Welker; Stefan Zeuzem; Eva Herrmann; Yolanda Martinez; Albrecht Piiper; David Reichert; Christoph Sarrazin; Simone Susser; Bernd Kronenberger
Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity.
PloS one 2012;7(2):e30796.
2012: Bernd Kronenberger; Stefan Zeuzem
New developments in HCV therapy.
Journal of viral hepatitis 2012;19 Suppl 1():48-51.
2011: Harald Farnik; Eva Herrmann; Wolf Peter Hofmann; Christian Markus Lange; Christoph Sarrazin; Jörg Trojan; Martin Walter Welker; Stefan Zeuzem; Regina Allwinn; Annemarie Berger; Bernd Kronenberger
Nucleos(t)ide analogue treatment reduces apoptotic activity in patients with chronic hepatitis B.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2011;52(3):204-9.
2011: Verena Bihrer; Nicole Forestier; Mireen Friedrich-Rust; Jörg Haupenthal; Eva Herrmann; Bernd Kronenberger; Jan Peveling-Oberhag; Heinfried H Radeke; Christoph Sarrazin; Ying Shi; Oliver Waidmann; Stefan Zeuzem; Albrecht Piiper
Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
The American journal of gastroenterology 2011;106(9):1663-9.
2011: Martin Walter Welker; Stefan Zeuzem; Eva Herrmann; Wolf Peter Hofmann; Christian Markus Lange; Christoph Sarrazin; Bernd Kronenberger
CD81 expression for discrimination between sustained virologic response and relapse in patients with chronic hepatitis C.
Scandinavian journal of gastroenterology 2011;46(7-8):973-80.
2011: Georg Dultz; Alireza Azizi; Bernd Kronenberger; Ulrike Mihm; Christoph Sarrazin; Ulrike Sarrazin; Thomas J Vogl; Stefan Zeuzem; Wolf Peter Hofmann
Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura.
Journal of hepatology 2011;55(1):229-32.
2011: Martin Walter Welker; Christoph Welsch; D Ochs; W P Hofmann; Eva Herrmann; Albrecht Piiper; Rolf W Hartmann; Stefan Zeuzem; Christoph Sarrazin; Bernd Kronenberger
Comparison of envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates.
Journal of viral hepatitis 2011;18(3):181-92.
2011: Verena Bihrer; Nicole Forestier; Mireen Friedrich-Rust; Jörg Haupenthal; Bernd Kronenberger; Jan Peveling-Oberhag; Andreas Polta; Heinfried H Radeke; Christoph Sarrazin; Ying Shi; Simone Susser; Jörg Trojan; Michael von Wagner; Oliver Waidmann; Martin Walter Welker; Stefan Zeuzem; Albrecht Piiper
Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.
PloS one 2011;6(10):e26971.
2010: Harald Farnik; Christian M Lange; Christoph Sarrazin; Bernd Kronenberger; Stefan Zeuzem; Eva Herrmann
Meta-analysis shows extended therapy improves response of patients with chronic hepatitis C virus genotype 1 infection.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2010;8(10):884-90.
2010: Martin Walter Welker; Michael von Wagner; Dana Ochs; Vincent Zimmer; Wolf Peter Hofmann; Albrecht Piiper; Rolf W Hartmann; Eva Herrmann; Stefan Zeuzem; Bernd Kronenberger
Influence of amantadine on CD81 expression on lymphocytes in chronic hepatitis C.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2010;42(10):735-40.
2010: Martin Walter Welker; Christoph Welsch; Aline Meyer; Iris Antes; Mario Albrecht; Nicole Forestier; Bernd Kronenberger; Thomas Lengauer; Albrecht Piiper; Stefan Zeuzem; Christoph Sarrazin
Dimerization of the hepatitis C virus nonstructural protein 4B depends on the integrity of an aminoterminal basic leucine zipper.
Protein science : a publication of the Protein Society 2010;19(7):1327-36.
2009: Bernd Kronenberger; Stefan Zeuzem
Current and future treatment options for HCV.
Annals of hepatology 2009;8(2):103-12.
2009: Bernd Kronenberger; Stefan Zeuzem
Treatment of chronic hepatitis C: anticipated impact of resistance in patients treated with protease inhibitors.
Current gastroenterology reports 2009;11(1):15-21.
2008: W P Hofmann; Bernd Kronenberger; Jörg Bojunga; B Stamm; Eva Herrmann; A Bücker; U Mihm; Michael von Wagner; Stefan Zeuzem; Christoph Sarrazin
Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy.
Journal of viral hepatitis 2008;15(11):790-6.
2008: Tanja M Raedle-Hurst; Christoph Welsch; Nicole Forestier; Bernd Kronenberger; Georg Hess; Eva Herrmann; Stefan Zeuzem; Jochen Raedle
Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver disease.
European journal of gastroenterology & hepatology 2008;20(9):865-73.
2008: Bernd Kronenberger; Christoph Welsch; Nicole Forestier; Stefan Zeuzem
Novel hepatitis C drugs in current trials.
Clinics in liver disease 2008;12(3):529-55, viii.
2008: Bernd Kronenberger; Stefan Zeuzem
Future treatment options for HCV: double, triple, what is the optimal combination?
Best practice & research. Clinical gastroenterology 2008;22(6):1123-36.
2007: Bernd Kronenberger; Thomas Berg; Eva Herrmann; Holger Hinrichsen; Tilman Gerlach; Peter Buggisch; Ulrich Spengler; Tobias Goeser; Samer Nasser; Karsten Wursthorn; Gerd R Pape; Uwe Hopf; Stefan Zeuzem
Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial.
European journal of gastroenterology & hepatology 2007;19(8):639-46.
2007: Wolf Peter Hofmann; B Fernandez; Eva Herrmann; Christoph Welsch; Ulrike Mihm; Bernd Kronenberger; G Feldmann; U Spengler; Stefan Zeuzem; Christoph Sarrazin
Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases.
Journal of viral hepatitis 2007;14(7):484-91.
2007: Wolf Peter Hofmann; Andreas Polta; Eva Herrmann; Ulrike Mihm; Bernd Kronenberger; Tanja Sonntag; Volker Lohmann; Barbara Schönberger; Stefan Zeuzem; Christoph Sarrazin
Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy.
Gastroenterology 2007;132(3):921-30.
2007: Bernd Kronenberger; Stefan Zeuzem; Christoph Sarrazin; Ulrike Mihm; Michael von Wagner; Wolf Peter Hofmann; Albrecht Piiper; Eva Herrmann
Dynamics of apoptotic activity during antiviral treatment of patients with chronic hepatitis C.
Antiviral therapy 2007;12(5):779-87.
2006: Michael von Wagner; J-H Lee; Bernd Kronenberger; R Friedl; Christoph Sarrazin; Gerlinde Teuber; Eva Herrmann; Stefan Zeuzem
Impaired health-related quality of life in patients with chronic hepatitis C and persistently normal aminotransferase levels.
Journal of viral hepatitis 2006;13(12):828-34.
2006: Bernd Kronenberger; Eva Herrmann; Wolf Peter Hofmann; Heiner Wedemeyer; Martina Sester; Ulrike Mihm; Temam Ghaliai; Stefan Zeuzem; Christoph Sarrazin
Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis C.
Journal of leukocyte biology 2006;80(2):298-308.
2006: Ulrike Mihm; Natalia Grigorian; Christoph Welsch; Eva Herrmann; Bernd Kronenberger; Gerlinde Teuber; Michael von Wagner; Wolf Peter Hofmann; Mario Albrecht; Thomas Lengauer; Stefan Zeuzem; Christoph Sarrazin
Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C.
Antiviral therapy 2006;11(4):507-19.
2005: Bernd Kronenberger; M Wagner; Eva Herrmann; Ulrike Mihm; Albrecht Piiper; Christoph Sarrazin; Stefan Zeuzem
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
Journal of viral hepatitis 2005;12(3):307-14.
2005: Ulrike Mihm; Wolf Peter Hofmann; Bernd Kronenberger; Michael von Wagner; Stefan Zeuzem; Christoph Sarrazin
Highly sensitive hepatitis C virus RNA detection assays for decision of treatment (dis)continuation in patients with chronic hepatitis C.
Journal of hepatology 2005;42(4):605-6.
2004: Bernd Kronenberger; Eva Herrmann; Florence Micol; Michael von Wagner; Stefan Zeuzem
Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels.
Hepatology (Baltimore, Md.) 2004;40(6):1442-9.
2004: Joerg Trojan; Angela Brieger; Jochen Raedle; Nicole Weber; Susanne Kriener; Bernd Kronenberger; Wolfgang F Caspary; Stefan Zeuzem
BAX and caspase-5 frameshift mutations and spontaneous apoptosis in colorectal cancer with microsatellite instability.
International journal of colorectal disease 2004;19(6):538-44.
2004: Wolf Peter Hofmann; Eva Herrmann; Bernd Kronenberger; Christian Merkwirth; Christoph Welsch; Thomas Lengauer; Stefan Zeuzem; Christoph Sarrazin
Association of HCV-related mixed cryoglobulinemia with specific mutational pattern of the HCV E2 protein and CD81 expression on peripheral B lymphocytes.
Blood 2004;104(4):1228-9.
2004: Bernd Kronenberger; Christoph Sarrazin; Wolf Peter Hofmann; Michael von Wagner; Eva Herrmann; Christoph Welsch; Robert Elez; Brigitte Rüster; Albrecht Piiper; Stefan Zeuzem
Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression.
Journal of viral hepatitis 2004;11(4):310-8.
2004: Ulrike Mihm; Eva Herrmann; Ulrike Sarrazin; Michael von Wagner; Bernd Kronenberger; Stefan Zeuzem; Christoph Sarrazin
Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C.
Journal of hepatology 2004;40(5):845-52.
2003: Michael von Wagner; J-H Lee; Brigitte Rüster; Bernd Kronenberger; Christoph Sarrazin; W K Roth; Stefan Zeuzem
Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment.
Journal of viral hepatitis 2003;10(6):413-22.
2003: Thomas Berg; Bernd Kronenberger; Holger Hinrichsen; Tilman Gerlach; Peter Buggisch; Eva Herrmann; Ulrich Spengler; Tobias Goeser; Samer Nasser; Karsten Wursthorn; Gerd R Pape; Uwe Hopf; Stefan Zeuzem
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial.
Hepatology (Baltimore, Md.) 2003;37(6):1359-67.
2003: Wolf Peter Hofmann; Christoph Sarrazin; Bernd Kronenberger; Barbara Schönberger; Katharina Bruch; Stefan Zeuzem
Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.
The Journal of infectious diseases 2003;187(6):982-7.
2003: Ulrike Mihm; Christoph Sarrazin; Eva Herrmann; Gerlinde Teuber; Michael von Wagner; Bernd Kronenberger; Stefan Zeuzem
Response predictors and results of a long-term treatment with lamivudine in patients with chronic hepatitis B.
Zeitschrift für Gastroenterologie 2003;41(3):249-54.
2003: Albrecht Piiper; Robert Elez; Se-Jong You; Bernd Kronenberger; Stefan Loitsch; Serge Roche; Stefan Zeuzem
Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
The Journal of biological chemistry 2003;278(9):7065-72.
2003: Albrecht Piiper; Manfred P Lutz; Henning Cramer; Robert Elez; Bernd Kronenberger; Ivan Dikic; Werner Müller-Esterl; Stefan Zeuzem
Protein kinase A mediates cAMP-induced tyrosine phosphorylation of the epidermal growth factor receptor.
Biochemical and biophysical research communications 2003;301(4):848-54.
2003: Robert Elez; Albrecht Piiper; Bernd Kronenberger; Martin Kock; Martin Brendel; Eva Hermann; Uwe Pliquett; Eberhardt Neumann; Stefan Zeuzem
Tumor regression by combination antisense therapy against Plk1 and Bcl-2.
Oncogene 2003;22(1):69-80.
2002: Albrecht Piiper; Ivan Dikic; Manfred P Lutz; Jürgen Leser; Bernd Kronenberger; Robert Elez; Henning Cramer; Werner Müller-Esterl; Stefan Zeuzem
Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells.
The Journal of biological chemistry 2002;277(46):43623-30.
2002: Joerg Trojan; Bernd Kronenberger; Michael von Wagner; Stefan Zeuzem
Lack of birth defects after paternal exposure to lamivudine.
Journal of hepatology 2002;36(4):571.
2001: Bernd Kronenberger; Brigitte Rüster; Robert Elez; S Weber; Albrecht Piiper; Jung-Hun Lee; W Kurt Roth; Stefan Zeuzem
Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2001;33(6):1518-26.
2000: Bernd Kronenberger; Brigitte Rüster; JH Lee; Christoph Sarrazin; W Kurt Roth; G Herrmann; Stefan Zeuzem
Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels.
Journal of hepatology 2000;33(4):640-7.
2000: Christoph Sarrazin; Brigitte Rüster; JH Lee; Bernd Kronenberger; W Kurt Roth; Stefan Zeuzem
Prospective follow-up of patients with GBV-C/HGV infection: specific mutational patterns, clinical outcome, and genetic diversity.
Journal of medical virology 2000;62(2):191-8.
2000: Albrecht Piiper; R Gebhardt; Bernd Kronenberger; C D Giannini; Robert Elez; Stefan Zeuzem
Pertussis toxin inhibits cholecystokinin- and epidermal growth factor-induced mitogen-activated protein kinase activation by disinhibition of the cAMP signaling pathway and inhibition of c-Raf-1.
Molecular pharmacology 2000;58(3):608-13.
2000: Christoph Sarrazin; I Kornetzky; Brigitte Rüster; JH Lee; Bernd Kronenberger; Katharina Bruch; W Kurt Roth; Stefan Zeuzem
Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response.
Hepatology (Baltimore, Md.) 2000;31(6):1360-70.
2000: Christoph Sarrazin; Thomas Berg; JH Lee; Brigitte Rüster; Bernd Kronenberger; W Kurt Roth; Stefan Zeuzem
Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response.
The Journal of infectious diseases 2000;181(2):432-41.
1999: Roman A Blaheta; Bernd Kronenberger; Dirk Woitaschek; C Schick; Elsie Oppermann; Marcus K H Auth; Alastair J Strain; S Weber; Albrecht Encke; Bernd H Markus
Interference of soluble mediators into liver matrix triggered dedifferentiation of human hepatocytes.
Transplantation proceedings 1999;31(1-2):502-4.
1998: Roman A Blaheta; Bernd Kronenberger; Dirk Woitaschek; Marcus K H Auth; Martin Scholz; S Weber; Horst Schuldes; Albrecht Encke; Bernd H Markus
Dedifferentiation of human hepatocytes by extracellular matrix proteins in vitro: quantitative and qualitative investigation of cytokeratin 7, 8, 18, 19 and vimentin filaments.
Journal of hepatology 1998;28(4):677-90.
1998: Roman A Blaheta; Bernd Kronenberger; Dirk Woitaschek; S Weber; Martin Scholz; Horst Schuldes; Albrecht Encke; Bernd H Markus
Development of an ultrasensitive in vitro assay to monitor growth of primary cell cultures with reduced mitotic activity.
Journal of immunological methods 1998;211(1-2):159-69.
1995: A J Schröder; Roman A Blaheta; M Scholz; Bernd Kronenberger; Albrecht Encke; Bernd H Markus
Effects of proinflammatory cytokines on cultivated primary human hepatocytes. Fluorometric measurement of intercellular adhesion molecule-1 and human leukocyte antigen-A, -B, -C, and -DR expression.
Transplantation 1995;59(7):1023-8.